Dr. Mamata Katdare, DGM (Biotech R&D), Biosciences Centre
Unichem Laboratories Ltd., Goa, India
“We have been working with Proteomics International for last 2-3 years for availing the analytical services of Biosimilars/Biologics Drug Characterisation. Our experience has been excellent. PI has offered us timely support to meet the time-lines by completing the sample analysis with data interpretations within the specified time frames. The data and the analysis reports were shared with Regulatory Agency and got accepted. PI was very prompt in answering the queries raised by the Agency.”
Jaap den Engelsman, Chief Financial Officer
BiosanaPharma B.V., The Netherlands
“In our wish to work with Australian partners during our biologic development program, we found in PI the only professional commercial laboratory able to help us in our protein characterization and stability testing needs.
PI combines a vast knowledge of protein chemistry with a customer-oriented approach and the flexibility biotech needs. PI’s work for us has helped us enormously to assess our cell line accuracy and manufacturing capabilities, the wide range of technologies offered by PI helps us to keep the number of service providers manageable.
Through networking with other Australian providers and Commercialisation Australia, we got aware of PI and the services offered. After two face-to-face meetings we were convinced of PI’s capabilities.
PI’s flexibility and understanding of customer’s needs helped us to maximize the value of the results of the outsourced activities, and demonstrates PI’s interest to also add value to their offered services and the potential to stimulate growth and performance.”
Dandan Chen, Head of Quality
The a2 Milk Company, Australia
“We selected Proteomics International due to their technical expertise in protein testing. We have found Proteomics International to be very customer focused and responsive to our requests and meet our commercial needs.”
Dr. Vijay Nag, Head-Regulatory
MJ Biotech Pvt. Ltd., Pune, India
“Our association with Proteomics International (PI) dates from 2008, when we have done our first biosimilarity exercise with them, which was submitted to many national and international regulatory bodies as well as customers. The quality of the data has spoken for itself, with a through acceptance from all.
After that we were associated regularly and there is marked difference in their approach and infrastructure. PI has now become a trusted partner for us to associate for protein characterization services, with impeccable quality and delivery of results within the timeline.”
Mr. Ajit Chandgude, Group Lead
Cipla Ltd., Mumbai, India
“Very friendly and professional. Loved the follow-up and progress calls. The results of the study were well presented and easy to understand. Reports are concise, clear and credible.“